Last updated on July 2018

Study to Evaluate the Efficacy Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients


Brief description of study

This will be a double-blind, randomised, placebo-controlled parallel-arm phase II proof of concept in subjects with PD treated with a stable dose of levodopa who are experiencing both end-of-dose wearing off and Levodopa-Induced Dyskinesia (LID)

Clinical Study Identifier: NCT03162874

Contact Investigators or Research Sites near you

Start Over

Franck Durif, MD

CHU Gabriel-Montpied
Clermont-Ferrand, France
  Connect »